{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T16:28:08Z","timestamp":1789921688548,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":3957,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1093\/annonc\/mdn589","type":"journal-article","created":{"date-parts":[[2008,8,26]],"date-time":"2008-08-26T00:34:10Z","timestamp":1219710850000},"page":"358-364","source":"Crossref","is-referenced-by-count":66,"title":["Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case\u2013control study"],"prefix":"10.1016","volume":"20","author":[{"given":"E.R.","family":"Koomen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Joosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.C.","family":"Herings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.K.","family":"Casparie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.J.","family":"Guchelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Nijsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdn589_bb0010","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ijc.2910420603","article-title":"The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women","volume":"42","author":"\u00d8sterlind","year":"1988","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdn589_bb0015","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/sj.bjc.6600196","article-title":"A pooled analysis of 10 case-control studies of melanoma and oral contraceptive use","volume":"86","author":"Karagas","year":"2002","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1093\/annonc\/mdn589_bb0020","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/annonc\/mdm498","article-title":"Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site","volume":"19","author":"de Vries","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdn589_bb0025","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/annonc\/mdm087","article-title":"Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands","volume":"18","author":"de Vries","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdn589_bb0030","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.ejca.2007.09.004","article-title":"Is statin use associated with a reduced incidence, reduced Breslow thickness or delayed metastasis of melanoma of the skin?","volume":"43","author":"Koomen","year":"2007","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1093\/annonc\/mdn589_bb0035","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/00007611-198011000-00023","article-title":"Malignant melanoma associated with breast cancer","volume":"73","author":"Schoenberg","year":"1980","journal-title":"South Med J"},{"issue":"8","key":"10.1093\/annonc\/mdn589_bb0040","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1200\/JCO.1987.5.8.1256","article-title":"Estrogen receptor in malignant melanoma","volume":"5","author":"Walker","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdn589_bb0045","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/bjc.1977.265","article-title":"Malignant melanoma and oral contraceptive use among women in California","volume":"36","author":"Beral","year":"1977","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdn589_bb0050","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/bjc.1981.211","article-title":"Malignant melanoma and oral contraceptives","volume":"44","author":"Kay","year":"1981","journal-title":"Br J Cancer"},{"issue":"6 Suppl","key":"10.1093\/annonc\/mdn589_bb0055","first-page":"345","volume":"25","author":"Ramcharan","year":"1980","journal-title":"J Reprod Med"},{"key":"10.1093\/annonc\/mdn589_bb0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/bjc.1981.145","article-title":"A case-control study of the possible association between oral contraceptives and malignant melanoma","volume":"44","author":"Adam","year":"1981","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1093\/annonc\/mdn589_bb0065","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/ije\/19.3.522","article-title":"Cutaneous malignant melanoma in females: the role of hormonal and reproductive factors","volume":"19","author":"Zanetti","year":"1990","journal-title":"Int J Epidemiol"},{"key":"10.1093\/annonc\/mdn589_bb0070","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/bjc.1991.99","article-title":"Oral contraceptives and malignant melanoma","volume":"63","author":"Hannaford","year":"1991","journal-title":"Br J Cancer"},{"issue":"10","key":"10.1093\/annonc\/mdn589_bb0075","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/oxfordjournals.aje.a117361","article-title":"Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive use","volume":"141","author":"Holly","year":"1995","journal-title":"Am J Epidemiol"},{"key":"10.1093\/annonc\/mdn589_bb0080","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/bjc.1996.216","article-title":"Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors","volume":"73","author":"Westerdahl","year":"1996","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1093\/annonc\/mdn589_bb0085","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/sj.bjc.6690787","article-title":"Oral contraceptive use and risk of melanoma in premenopausal women","volume":"81","author":"Feskanich","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdn589_bb0090","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/BF00052752","article-title":"Oral contraceptive use and risk of cutaneous malignant melanoma","volume":"3","author":"Palmer","year":"1992","journal-title":"Cancer Causes and Control"},{"key":"10.1093\/annonc\/mdn589_bb0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00124252","article-title":"Oral contraceptive use and risk of cutaneous malignant melanoma in case-control study of French women","volume":"3","author":"L\u00ea","year":"1992","journal-title":"Cancer Causes and Control"},{"key":"10.1093\/annonc\/mdn589_bb0100","unstructured":"PHARMO pharmacy database http:\/\/www.pharmo.nl\/ (23 November 2007, date last accessed)"},{"key":"10.1093\/annonc\/mdn589_bb0105","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0895-4356(97)00040-1","article-title":"Validation of pharmacy records in drug exposure assessment","volume":"50","author":"Lau","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"10.1093\/annonc\/mdn589_bb0110","series-title":"Pharmo, A Record Linkage System for Postmarketing Surveillance of Prescription Drugs in the Netherlands [Thesis in Pharmaco-Epidemiology and Pharmacotherapy]","first-page":"17","author":"Herings","year":"1993"},{"issue":"1","key":"10.1093\/annonc\/mdn589_bb0115","first-page":"19","article-title":"Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive","volume":"29","author":"Casparie","year":"2007","journal-title":"Cell Oncol"},{"key":"10.1093\/annonc\/mdn589_bb0120","doi-asserted-by":"crossref","first-page":"163","DOI":"10.7326\/0003-4819-147-8-200710160-00010-w1","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration","volume":"147","author":"Vandenbroucke","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1093\/annonc\/mdn589_bb0125","series-title":"WHO Classification of Tumours Volume 6, IARC WHO Classification of Tumours No 6, Pathology and Genetics of Tumours of the Skin","author":"LeBoit","year":"2005"},{"issue":"21","key":"10.1093\/annonc\/mdn589_bb0130","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/jnci\/djj412","article-title":"Statins, fibrates, and melanoma risk: a systematic review and meta-analysis","volume":"98","author":"Freeman","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdn589_bb0135","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2133.2005.06386.x","article-title":"Predictions of skin cancer incidence in The Netherlands up to 2015","volume":"152","author":"de Vries","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1093\/annonc\/mdn589_bb0140","unstructured":"Centraal Bureau voor de Statistiekhttp:\/\/www.statline.cbs.nl\/ (18 February 2007, date last accessed)"},{"key":"10.1093\/annonc\/mdn589_bb0145","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ijc.20473","article-title":"In vitro and in vivo antitumor effect of 2-methoxyestradiol on human melanoma","volume":"112","author":"Dobos","year":"2004","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1093\/annonc\/mdn589_bb0150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnci\/dji047","article-title":"Sunlight and reduced risk of cancer: is the real story vitamin D?","volume":"97","author":"Egan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdn589_bb0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0378-5122(95)00964-7","article-title":"Sociological and behavioral characteristics of perimenopausal women with an express attitude to hormone substitution therapy","volume":"23","author":"Jensen","year":"1996","journal-title":"Maturitas"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419404766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419404766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/20\/2\/358\/391722\/mdn589.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T12:29:27Z","timestamp":1582201767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419404766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0923753419404766"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdn589","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}